133 results
6-K
TAK
Takeda Pharmaceutical Co
3 Jun 24
Current report (foreign)
6:45am
of muscle tone) frequency versus placebo that were also sustained over 8 weeks.
The majority of NT1 patients in the trial were found to be within … normative ranges for MWT and ESS by the end of the 8-week treatment period as a result of these sustained improvements.
The majority of the participants
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
short- and long-term incentives with company performance We tie the majority of the TET compensation to long-term performance We utilize a total
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
and clinically meaningful, consistent with the primary endpoint. The majority of patients who completed the trial entered a long-term extension study. Based
6-K
TAK
Takeda Pharmaceutical Co
9 Feb 24
Current report (foreign)
6:03am
and clinically meaningful, consistent with the primary endpoint. The majority of patients who completed the trial entered a long-term extension study
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
to strengthen supervisory functions and make deliberations more objective and transparent, Independent External Directors comprise a majority … , the majority, are Independent External Directors (including four Independent External Directors who are ASC Members). The BOD meeting is chaired
6-K
EX-99.1
aqz c11on
12 Jul 23
Current report (foreign)
6:07am
6-K
f38ggzc
3 Jul 23
Current report (foreign)
6:02am
S-8
EX-99.2
6as67zehv hrlbzp
28 Jun 23
Registration of securities for employees
6:35am
6-K
EX-99.1
7mk7sp3 t66c
23 Jun 23
Current report (foreign)
6:13am
6-K
nf5jul9krvo3w
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
bjma8xwhdtn6jh18 3r
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
wtkp7
30 May 23
Current report (foreign)
6:11am
6-K
q4n4806
4 Nov 22
Current report (foreign)
6:01am
6-K
EX-99.1
0qw4hl1r78a 89r60
4 Aug 22
Current report (foreign)
6:07am
6-K
np9feu9cdhwff
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
0r3m9nnq1ulr8beuk7i6
28 Jul 22
Current report (foreign)
6:09am
6-K
mglnd r5mibh6lx7y901
11 Jul 22
Current report (foreign)
6:05am
6-K
5feb1x5rm3766un9nho
5 Jul 22
Current report (foreign)
6:09am